Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Kavitha Ramchandran

Clinical Associate Professor

Stanford University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (14)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (10)

Gerald Berry

Professor of Pathology

Stanford University

UNITED STATES

View details

Han Zhu

Stanford University School of Medicine

UNITED STATES

View details

Yufei Liu

Assistant Clinical Professor

City of Hope

UNITED STATES

View details

Sean Wu

Associate Professor of Medicine

Stanford University School of Medicine

UNITED STATES

View details

surbhi singhal

Member

University of California, Davis

UNITED STATES

View details

Arash Ash Alizadeh

Professor of Medicine

Stanford University School of Medicine

UNITED STATES

View details

Chloe Su

Stanford University

UNITED STATES

View details

Seema Nagpal

UNITED STATES

View details

David Kurtz

Assistant Professor

Stanford University

UNITED STATES

View details

Mohammad Shahrokh Esfahani

Assistant Professor

Stanford University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kavitha Ramchandran

Research Interests

Explore related searches

Articles (14)

KRAS G12C inhibitor outcomes in advanced non-small cell lung cancer by smoking history, performance status, and KEAP1 mutation status.

Corrigendum to 'Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System-Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes' [JTO Clinical and Research Reports 6 (2025) 100914].

Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology.

Corrigendum to "KRAS G12C inhibitor outcomes in advanced non-small cell lung cancer by smoking history, performance status, and KEAP1 mutation status" [Cancer Treatment and Research Communications 47 (2026) 101227].

Feasibility of Panitumumab-IRDye800 molecular imaging for intraoperative tumor localization of lung cancer

Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer

Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer

Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy.

Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System- Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes

DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed<i> EGFR</i>-Mutant Lung Cancer and Two Cases of Tarlatamab Therapy

Nativity status and non-small cell lung cancer outcomes

QIM25-226: What Patients Anticipate About Working Out with Cancer: Qualitative Survey Results.

Comparison of 1-year mortality predictions from vendor-supplied versus academic model for cancer patients.

Brief Report: Prospective Trial of Pembrolizumab Monotherapy in Metastatic NSCLC Evaluating Circulating Tumor DNA as a Surrogate Biomarker of Response.

Collaborators (10)

Gerald Berry

Han Zhu

Yufei Liu

Sean Wu

surbhi singhal

Arash Ash Alizadeh

Chloe Su

Seema Nagpal

David Kurtz

Mohammad Shahrokh Esfahani

Make your next move.